RABI-767 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Part
Phase 2 · Acute Pancreatitis |
Panafina, Inc. | RABI-767 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|